Startups
NovaScan’s leadership believes that improving the detection and stratification of cancer – be it in initial detection of cancer, during a procedure, or in post-procedural pathology – can improve patient outcomes, increase physician economics, and reduce the cost of care. We are committed to commercializing our platform technology for cancer detection and stratification, which we believe offers significant advantages over alternatives in soft tissue cancer detection. NovaScan’s first product, MarginScan Skin, offers dermatologists the opportunity for fast, predictable healthy tissue sparing skin cancer procedures.
Overview
Location
United States, Illinois, Chicago
Employees
11-50
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 8, 2024 | NovaScan and Dr Paul Grippo Receive Competitive Award for Pancreatic Cancer Research | CHICAGO, IL, USA, February 8, 2024 /EINPresswire.com/ -- NovaScan, a clinical-stage oncology company based in Chicago, today announced that a collaboration with Dr Paul Grippo, Associate Professor of Gastroenterology and Hepatology at the U... |
| Jan 9, 2023 | NovaScan Announces the Launch of a Human GI trial for its nsCanary™ Cancer Detection Device | CHICAGO, IL, USA, January 9, 2023 /EINPresswire.com/ -- NovaScan, a clinical stage oncology company based in Chicago, announced that it has started a human GI clinical trial for its nsCanary™ device at Texas International Endoscopy Center (... |
| Aug 9, 2022 | Dr Amit Mehta to Advise NovaScan on Ex Vivo Scanning Product | CHICAGO, IL, USA, August 9, 2022 /EINPresswire.com/ -- NovaScan, an emerging oncology company based in Chicago, has announced that Dr Amit Mehta will guide NovaScan on the development of its ex vivo offerings for both gastroenterology and p... |
| May 2, 2022 | NovaScan announces Luminary Scientific Advisory Board Leaders in Pulmonary and Gastroenterology | CHICAGO, IL, USA, May 2, 2022 /EINPresswire.com/ -- Chicago IL: NovaScan, a clinical-stage oncology company based in Chicago, has announced the appointment of luminaries in interventional pulmonology and gastroeneterology to lead initiative... |
| NovaScan |
Reviews 0
FAQ about NovaScan
What has the press written about NovaScan?
Parsers VC has collected 6 articles mentioning NovaScan, among them “NovaScan and Dr Paul Grippo Receive Competitive Award for Pancreatic Cancer Research” (Feb 8, 2024) and “NovaScan Announces the Launch of a Human GI trial for its nsCanary™ Cancer Detection Device” (Jan 9, 2023).
Is NovaScan still active?
Yes, NovaScan is active; its latest activity on Parsers VC dates from Oct 22, 2024.